Counterpoint: clinical islet transplantation: not ready for prime time.
Khan
Mahfuzul H
MH
Harlan
David M
DM
D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000401:mortality / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000097:blood / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation / Q000009:adverse effects* / Q000639:trends*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000706:statistics & numerical data; D016035:Pancreas Transplantation / Q000276:immunology / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000453:epidemiology; D011379:Prognosis; D012307:Risk Factors; D012449:Safety; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D003404:Creatinine